Current treatment of Cutaneous T-Cell Lymphoma.

M Duvic

Journal: Dermatology online journal 2001;7(1):3

PMID: 11328624

Free Full Text on Arthur C Huntley MD, California Digital Library View on PubMed

Abstract

Cutaneous T-cell lymphomas are a heterogeneous group of cutaneous non-Hodgkin's lymphomas. In the United States, the incidence of these diseases is rising faster than any other cancer. Environmental triggers may be important in the evolution of malignancy. Current therapy is reviewed with emphasis on a new retinoid, Targretin.

Address: University of Texas, MD Anderson Cancer Center, USA.

Link outs

Free resources

Full Text Sources:

http://escholarship.org/uc/item/3bs957xs

MeSH Terms: Administration, Oral, Administration, Topical, Anticarcinogenic Agents, Apoptosis, Bexarotene, Biopsy, Carmustine, Disease Progression, Drug Eruptions, Humans, Hypertriglyceridemia, Lymphoma, T-Cell, Cutaneous, Mechlorethamine, Neoplasm Staging, PUVA Therapy, Prognosis, Retinoids, Sezary Syndrome, Tetrahydronaphthalenes, Vitamin D